Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells

Molecular Pharmacology

Volumn 67, Issue 3, 2005, Pages 965-975

  Mollereau, Catherine ^a   Mazarguil, Honoré ^a   Zajac, Jean Marie ^a   Roumy, Michel ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL; CALCIUM CHANNEL N TYPE; CARBACHOL; CLONIDINE; CYCLIC AMP; DELTA OPIATE RECEPTOR; DELTORPHIN; DELTORPHIN 1; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; MU OPIATE RECEPTOR; MUSCARINIC RECEPTOR; NEUROPEPTIDE FF DERIVATIVE; NEUROPEPTIDE FF2 RECEPTOR; NEUROPEPTIDE RECEPTOR; OPIATE; OPIATE ANTAGONIST; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELL MEMBRANE; HUMANS; NEUROBLASTOMA; NEUROPEPTIDES; OLIGOPEPTIDES; PEPTIDE FRAGMENTS; RECEPTORS, NEUROPEPTIDE; RECEPTORS, OPIOID, MU;

EID: 14944386543     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.004614     Document Type: Article

References (37)

1. Ballet S, Braz J, Mauborgne A, Bourgoin S, Zajac JM, Hamon M, and Cesselin F (2002) The neuropeptide FF analogue, 1DMe, reduces in vivo dynorphin release from the rat spinal cord. J Neurochem 81:659-662.
2. Ballet S, Mauborgne A, Gouarderes C, Bourgoin AS, Zajac JM, Hamon M, and Cesselin F (1999) The neuropeptide FF analogue, 1DMe, enhances in vivo metenkephalin release from the rat spinal cord. Neuropharmacology 38:1317-1324.
3. Bonini JA, Jones KA, Adham N, Forray C, Artymyshyn R, Durkin MM, Smith KE, Tamm JA, Boteju LW, Lakhlani PP, et al. (2000) Identification and characterization of two G protein-coupled receptors for neuropeptide FF. J Biol Chem 275:39324-39331.
4. Carter BD and Medzihradsky F (1993) Go mediates the coupling of the mu opioid receptor to adenylyl cyclase in cloned neural cells and brain. Proc Natl Acad Sci USA 90:4062-4066.
5. Chang M, Zhang L, Tam JP, and Sanders-Bush E (2000) Dissecting G protein-coupled receptor signaling pathways with membrane-permeable blocking peptides. Endogenous 5-HT(2C) receptors in choroid plexus epithelial cells. J Biol Chem 275:7021-7029.
6. Connor M and Henderson G (1996) delta- and mu-Opioid receptor mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells. Br J Pharmacol 117:333-340.
7. Cordeaux Y and Hill SJ (2002) Mechanisms of cross-talk between G-protein-coupled receptors. Neurosignals 11:45-57.
8. Crain SM and Shen KF (2000) Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain 84:121-131.
9. Elshourbagy NA, Ames RS, Fitzgerald LR, Foley JJ, Chambers JK, Szekeres PG, Evans NA, Schmidt DB, Buckley PT, Dytko GM, et al. (2000) Receptor for the pain modulatory neuropeptides NPFF and NPAF is an orphan G-protein-coupled receptor. J Biol Chem 275:25965-25971.
10. Gherardi N and Zajac J-M (1997) Neuropeptide FF receptors of mouse olfactory bulb: binding properties and stimulation of adenylate cyclase activity. Peptides 18:577-583.
11. Gilchrist A, Mazzoni MR, Dineen B, Dice A, Linden J, Proctor WR, Lupica CR, Dunwiddie TV, and Hamm HE (1998) Antagonists of the receptor-G protein interface block Gi-coupled signal transduction. J Biol Chem 273:14912-14919.
12. 125I]EYF: a new high affinity radioligand to neuropeptide FF receptors. Peptides 22:623-629.
13. Gouardères C, Tafani J-AM, and Zajac J-M (1998) Affinity of neuropeptide FF analogs to opioid receptors in the rat spinal cord. Peptides 19:727-730.
14. Harrison LM, Kastin AJ, and Zadina JE (1998) Opiate tolerance and dependence: receptors, G-proteins and antiopiates. Peptides 19:1603-1630.
15. Heinricher MM, McGaraughty S, and Tortorici V (2001) Circuitry underlying antiopioid actions of cholecystokinin within the rostral ventromedial medulla. J Neurophysiol 85:280-286.
16. Kazmi SM and Mishra RK (1987) Comparative pharmacological properties and functional coupling of μ and δ opioid receptor sites in human neuroblastoma SH-SY5Y cells. Mol Pharmacol 32:109-118.
17. Kotani M, Mollereau C, Detheux M, Le Poul E, Brezillon S, Vakili J, Mazarguil H, Vassart G, Zajac J-M, and Parmentier M (2001) Functional characterization of a human receptor for neuropeptide FF and related peptides. Br J Pharmacol 133:138-144.
18. Laugwitz KL, Offermanns S, Spicher K, and Schultz G (1993) mu and delta Opioid receptors differentially couple to G protein subtypes in membranes of human neuroblastoma SH-SY5Y cells. Neuron 10:233-242.
19. Law PY, Kouhen OM, Solberg J, Wang W, Erickson LJ, and Loh HH (2000) Deltorphin II-induced rapid desensitization of δ-opioid receptor requires both phosphorylation and internalization of the receptor. J Biol Chem 275:32057-32065.
20. Mauborgne A, Bourgoin S, Polienor H, Roumy M, Simonnet G, Zajac J-M, and Cesselin F (2001) The neuropeptide FF analogue, 1DMe, acts as a functional opioid autoreceptor antagonist in the rat spinal cord. Eur J Pharmacol 430:273-276.
21. 2A adenosine receptor. Mol Pharmacol 58:226-236.
22. Miller KK and Lupica CR (1997) Neuropeptide FF inhibition of morphine effects in the rat hippocampus. Brain Res 750:81-86.
23. Mollereau C, Mazarguil H, Marcus D, Quelven I, Kotani M, Lannoy V, Dumont Y, Quirion R, Detheux M, Parmentier M, et al. (2002) Pharmacological characterization of human NPFF(1) and NPFF(2) receptors expressed in CHO cells by using NPY Y(1) receptor antagonists. Eur J Pharmacol 451:245-256.
24. Noble F, Szucs M, Kieffer B, and Roques BP (2000) Overexpression of dynamin is induced by chronic stimulation of μ- but not δ-opioid receptors: relationships with μ-related morphine dependence. Mol Pharmacol 58:159-166.
25. Panula P, Kalso E, Nieminen M, Kontinen VK, Brandt A, and Pertovaara A (1999) Neuropeptide FF and modulation of pain. Brain Res 848:191-196.
26. 2+ channels in rat spinal ganglion neurones. Neuroreport 7:2979-2981.
27. Ross RA, Spengler BA, and Biedler JL (1983) Coordinate morphological and biochemical interconversion of human neuroblastoma cells. J Natl Cancer Inst 71:741-747.
28. Roumy M, Garnier M, and Zajac JM (2003) Neuropeptide FF receptors 1 and 2 exert an anti-opioid activity in acutely dissociated rat dorsal raphe and periventricular hypothalamic neurones. Neurosci Lett 348:159-162.
29. Roumy M and Zajac J-M (1998) Neuropeptide FF, pain and analgesia. Eur J Pharmacol 345:1-11.
30. Roumy M and Zajac J-M (1999) Neuropeptide FF selectively attenuates the effects of nociceptin on acutely dissociated neurons of the rat dorsal raphe nucleus. Brain Res 845:208-214.
31. Roumy M and Zajac J-M (2001) Neuropeptide FF receptors couple to a cholera toxin-sensitive G-protein in rat dorsal raphe neurones. Eur J Pharmacol 417:45-49.
32. Smart D, Smith G, and Lambert DG (1995) mu-Opioids activate phospholipase C in SH-SY5Y human neuroblastoma cells via calcium-channel opening. Biochem J 305:577-581.
33. Takeuchi T, Fujita A, Roumy M, Zajac J-M, and Hata F (2001) Effect of 1DMe, a neuropeptide FF analog, on acetylcholine release from myenteric plexus of guinea pig ileum. Jpn J Pharmacol 86:417-422.
34. Toll L, Polgar WE, and Auh JS (1997) Characterization of the delta-opioid receptor found in SH-SY5Y neuroblastoma cells. Eur J Pharmacol 323:261-267.
35. Vaughan PF, Peers C, and Walker JH (1995) The use of the human neuroblastoma SH-SY5Y to study the effect of second messengers on noradrenaline release. Gen Pharmacol 26:1191-1201.
36. Yeo A, Samways DS, Fowler CE, Gunn-Moore F, and Henderson G (2001) Coincident signalling between the Gi/Go-coupled delta-opioid receptor and the Gq-coupled m3 muscarinic receptor at the level of intracellular free calcium in SH-SY5Y cells. J Neurochem 76:1688-1700.
37. Zajac J-M (2001) Neuropeptide FF: new molecular insights. Trends Pharmacol Sci 22:63.